LSP eyes up to €150m for new fund to battle rising global dementia cases

European life science investor LSP has launched a dedicated fund targeting the fight against neurodegenerative diseases. The LSP Dementia Fund will be managed by Professor Philip Scheltens, a world-renowned dementia scientist and thought leader, the firm said. Never miss a story – click to sign up to AltAssets’ free daily PE newsletter About 50 million patients …